Cytochrome P450 Family 1 Inhibitors and Structure-Activity Relationships

被引:76
作者
Liu, Jiawang [1 ]
Sridhar, Jayalakshmi [1 ]
Foroozesh, Maryam [1 ]
机构
[1] Xavier Univ Louisiana, Dept Chem, New Orleans, LA 70125 USA
关键词
cytochrome P450; enzyme inhibitor; stilbenoids; flavonoids; structure activity relationships; mechanism-based inhibitor; ARYL-HYDROCARBON RECEPTOR; POLYCYCLIC AROMATIC-HYDROCARBONS; MECHANISM-BASED INACTIVATION; POTENT INHIBITION; P450; 1A1; CATALYTIC-ACTIVITY; HEPATIC ETHOXYRESORUFIN; PREVENTING ACTIVATION; METABOLIC-ACTIVATION; SELECTIVE INHIBITOR;
D O I
10.3390/molecules181214470
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
With the widespread use of O-alkoxyresorufin dealkylation assays since the 1990s, thousands of inhibitors of cytochrome P450 family 1 enzymes (P450s 1A1, 1A2, and 1B1) have been identified and studied. Generally, planar polycyclic molecules such as polycyclic aromatic hydrocarbons, stilbenoids, and flavonoids are considered to potentially be effective inhibitors of these enzymes, however, the details of the structure-activity relationships and selectivity of these inhibitors are still ambiguous. In this review, we thoroughly discuss the selectivity of many representative P450 family 1 inhibitors reported in the past 20 years through a meta-analysis.
引用
收藏
页码:14470 / 14495
页数:26
相关论文
共 109 条
  • [1] Aimova Dagmar, 2005, Biomedical Papers (Olomouc), V149, P437
  • [2] Cytochrome P450 CYP1A1: wider roles in cancer progression and prevention
    Androutsopoulos, Vasilis P.
    Tsatsakis, Aristidis M.
    Spandidos, Demetrios A.
    [J]. BMC CANCER, 2009, 9
  • [3] ASTROFF B, 1988, MOL PHARMACOL, V33, P231
  • [4] Rofecoxib is a potent inhibitor of cytochrome P450 1A2: studies with tizanidine and caffeine in healthy subjects
    Backman, Janne T.
    Karjalainen, Marjo J.
    Neuvonen, Mikko
    Laitila, Jouko
    Neuvonen, Pertti J.
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 62 (03) : 345 - 357
  • [5] Natural furocoumarins as inducers and inhibitors of cytochrome P450 1A1 in rat hepatocytes
    Baumgart, A
    Schmidt, M
    Schmitz, HJ
    Schrenk, D
    [J]. BIOCHEMICAL PHARMACOLOGY, 2005, 69 (04) : 657 - 667
  • [6] Targeting cytochrome P450 enzymes: A new approach in anti-cancer drug development
    Bruno, Robert D.
    Njar, Vincent C. O.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (15) : 5047 - 5060
  • [7] INHIBITION AND INACTIVATION OF MURINE HEPATIC ETHOXYRESORUFIN AND PENTOXYRESORUFIN O-DEALKYLASE BY NATURALLY-OCCURRING COUMARINS
    CAI, YN
    BENNETT, D
    NAIR, RV
    CESKA, O
    ASHWOODSMITH, MJ
    DIGIOVANNI, J
    [J]. CHEMICAL RESEARCH IN TOXICOLOGY, 1993, 6 (06) : 872 - 879
  • [8] Mechanism-based inactivation of hepatic ethoxyresorufin O-dealkylation activity by naturally occurring coumarins
    Cai, YN
    BaerDubowska, W
    AshwoodSmith, MJ
    Ceska, O
    Tachibana, S
    DiGiovanni, J
    [J]. CHEMICAL RESEARCH IN TOXICOLOGY, 1996, 9 (04) : 729 - 736
  • [9] Inhibitory effects of naturally occurring coumarins on the metabolic activation of benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene in cultured mouse keratinocytes
    Cai, YN
    BaerDubowska, W
    AshwoodSmith, M
    DiGiovanni, J
    [J]. CARCINOGENESIS, 1997, 18 (01) : 215 - 222
  • [10] Aryl hydrocarbon receptor activation by aminoflavone: New molecular target for renal cancer treatment
    Callero, Mariana A.
    Suarez, Guadalupe V.
    Luzzani, Gabriela
    Itkin, Boris
    Binh Nguyen
    Loaiza-Perez, Andrea I.
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2012, 41 (01) : 125 - 134